Status:
COMPLETED
Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?
Lead Sponsor:
Western Galilee Hospital-Nahariya
Conditions:
End Stage Renal Disease
Hemodialysis
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Addition of Heparin to the Catheter Lock Solution (CLS): Taurolock-TM will improve the vascular patency compared to Taurolock-TM alone , in hemodialysis patients with Tunneled Cuffed Catheter(TCC) as ...
Detailed Description
Bacteremia and thrombosis are the major complications of TCC used for hemodialysis.Instilation of CLS containing antibiotic-anticoagulant solution in the end of each dialysis session till the next dia...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Hemodialysis patients with new TCC
- Informed Consent
Exclusion
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
End Date :
August 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00749619
Start Date
May 1 2007
End Date
August 1 2008
Last Update
September 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Galilee Hospital
Nahariya, Israel